Big Pharma spent $2.4 billion on advertising from January through June, a 0.4 percent increase over the same period last year. The anemic growth rate contrasts with an overall 5.7 percent increase in all advertising spending during the same time.
In recent years, the advertising category that includes prescription drugs and pharmaceutical companies has leapt 20 percent to 40 percent quarterly, said Jeff King, senior vice president of Nielsen Monitor-Plus, Nielsen Media Research's advertising tracking arm. King cited a tougher stance by the Food and Drug Administration on drug advertising as the reason for the slump this year.
No comments:
Post a Comment